Church & Dwight Gummy Investment Targets Expanding Market
This article was originally published in The Tan Sheet
Church & Dwight expands its manufacturing capacity for gummy vitamins, citing strong sales growth in the category, and expects to use the format for some OTC products. Analysts expect interest in the gummy format to spread amongst manufacturers across the consumer health space.
You may also be interested in...
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.
The biotech is shifting gears after clinical hold on its lead drug was unlikely to be lifted, but the early-stage candidate that it's placing its hopes on is raising red flags for analysts and investors.
The biotech confirmed that a recent death during a clinical trial was not caused by its early-stage gene therapy.